The first non-injectable emergency treatment for allergies is anticipated to hit shelves following FDA approval of the neffy epinephrine nasal spray. The product from ARS Pharmaceuticals, previously ...

Many seeds and legumes that are not required to carry mandatory allergen warnings often cause severe allergic reactions, ...

The FDA added a boxed warning about rare cases of anaphylaxis associated with the multiple sclerosis (MS) drug glatiramer acetate (Copaxone, Glatopa), the agency announced on Wednesday. The warning ...

A new study by clinical researchers at Baylor College of Medicine and Texas Children’s Hospital offers insight on the primary triggers and management of childhood anaphylaxis. This severe, ...

The main treatment for anaphylaxis is epinephrine, usually given by injection. If you don’t have access to epinephrine, call 911 or seek emergency care immediately. The most effective way to manage ...

New research based on real-world data largely aligns with the scientific literature, although one monoclonal antibody—dupilumab—stood out for its very low risk. Patients receiving monoclonal ...

Anaphylaxis is a severe allergic reaction that usually affects multiple areas of the body at once. Sam Torbati, MD, a cochair and the medical director of the emergency department at Cedars-Sinai in ...

Anaphylaxis is the most extreme form of severe allergic reactions which can be life threatening and requires emergency medical treatment. It can affect anyone of any age, sex, race and stature.

Good news for those who suffer from severe allergic reactions: a nasal spray containing epinephrine rather than a needle can now treat those frightening moments. The treatment, called Neffy, was ...

Anaphylaxis can cause severe itching, difficulty breathing, fainting, and abdominal pain. These symptoms usually begin about 30 minutes after coming into contact with an allergy trigger. First, call ...

Patients with signs of anaphylaxis should be given epinephrine in the anterolateral thigh as first-line treatment, according to new practice parameters published in the December issue of the Annals of ...